Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew participant-focused navigation links were added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was standardized. The page version was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check20 days agoChange DetectedFooter revision tag updated from v3.5.4 to v3.5.5, signaling a new page version without altering the main content.SummaryDifference0.0%

- Check42 days agoChange DetectedThis change introduces Revision: v3.5.4 on the page, replacing Revision: v3.5.3. It represents an update to the page's versioning metadata and does not modify substantive content or study details.SummaryDifference0.0%

- Check56 days agoChange DetectedA new revision label, v3.5.3, has replaced the previous v3.5.2 on the page. This indicates a minor site update to the underlying system or template rather than a change to the study content.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the page header.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the page, reflecting a platform update.SummaryDifference0.0%

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.